Marinus Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Aug '25 Aug 1, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Market Capitalization	5,137	5,666	9,880	1,805	1,195	415	Upgrade
Market Cap Growth	-42.65%	-42.65%	447.26%	51.02%	188.23%	-	Upgrade
Enterprise Value	5,346	5,782	9,664	3,220	3,680	2,380	Upgrade
Last Close Price	19.81	21.85	38.10	7.40	4.90	1.70	Upgrade
PE Ratio	-	-	14.74	1.26	-	-	Upgrade
PS Ratio	18.88	20.83	116.61	1.03	2.45	2.33	Upgrade
PB Ratio	2.33	2.57	4.30	1.67	-0.67	-0.49	Upgrade
P/TBV Ratio	2.68	2.95	5.13	1.22	-	3.69	Upgrade
P/FCF Ratio	-	29.44	-	0.55	-	6.71	Upgrade
P/OCF Ratio	-	28.07	26487.51	0.55	-	6.68	Upgrade
EV/Sales Ratio	19.65	21.25	114.06	1.83	7.55	13.34	Upgrade
EV/EBITDA Ratio	-	-	-	2.50	36.17	-	Upgrade
EV/EBIT Ratio	-	-	-	2.51	37.79	-	Upgrade
EV/FCF Ratio	27.78	30.05	-	0.98	-	38.50	Upgrade
Debt / Equity Ratio	0.11	0.11	0.19	1.10	-2.08	-4.20	Upgrade
Debt / EBITDA Ratio	-	-	-	0.92	35.17	-	Upgrade
Debt / FCF Ratio	1.21	1.21	-	0.36	-	57.46	Upgrade
Asset Turnover	0.07	0.07	0.02	0.42	0.09	0.03	Upgrade
Inventory Turnover	0.05	0.05	0.01	0.10	0.04	0.05	Upgrade
Quick Ratio	0.05	0.05	0.11	0.05	0.01	0.04	Upgrade
Current Ratio	1.38	1.38	0.94	1.95	0.66	0.87	Upgrade
Return on Equity (ROE)	-3.81%	-3.81%	39.40%	-	-	-	Upgrade
Return on Assets (ROA)	-1.59%	-1.59%	-2.38%	19.00%	1.14%	-1.38%	Upgrade
Return on Capital (ROIC)	-2.33%	-2.33%	-3.41%	38.12%	2.62%	-2.58%	Upgrade
Return on Capital Employed (ROCE)	-	-	-	73.70%	-	-	Upgrade
Earnings Yield	-1.31%	-1.19%	6.78%	79.64%	-49.75%	-135.95%	Upgrade
FCF Yield	3.75%	3.40%	-0.22%	181.31%	-18.48%	14.91%	Upgrade
Buyback Yield / Dilution	-2.12%	-2.12%	-3.48%	-0.45%	-	-	Upgrade

Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.